{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:40:22Z","timestamp":1792118422016,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.amjmed.2023.06.020","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T21:11:48Z","timestamp":1689196308000},"page":"1011-1017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Testing Patterns and Disparities for Alpha-1 Antitrypsin Deficiency"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0204-2573","authenticated-orcid":false,"given":"Leonard","family":"Riley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryaman","family":"Sriram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Brantly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Lascano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjmed.2023.06.020_bib0001","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1164\/rccm.201108-1428CI","article-title":"A review of \u03b11-Antitrypsin deficiency","volume":"185","author":"Stoller","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2023.06.020_bib0002","doi-asserted-by":"crossref","first-page":"16051","DOI":"10.1038\/nrdp.2016.51","article-title":"\u03b11-Antitrypsin deficiency","volume":"2","author":"Greene","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"10.1016\/j.amjmed.2023.06.020_bib0003","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1513\/AnnalsATS.201611-838OC","article-title":"Alpha-1 antitrypsin PiMZ genotype is associated with chronic obstructive pulmonary disease in two racial groups","volume":"14","author":"Foreman","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.amjmed.2023.06.020_bib0004","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1164\/rccm.202106-1404OC","article-title":"Alpha-1 antitrypsin MZ heterozygosity is an endotype of chronic obstructive pulmonary disease","volume":"205","author":"Ghosh","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"9991","key":"10.1016\/j.amjmed.2023.06.020_bib0005","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0140-6736(15)60860-1","article-title":"Intravenous augmentation treatment and lung density in severe \u03b11 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial","volume":"386","author":"Chapman","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.amjmed.2023.06.020_bib0006","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1183\/09031936.00159408","article-title":"Exploring the role of CT densitometry: a randomised study of augmentation therapy in \u03b11-antitrypsin deficiency","volume":"33","author":"Dirksen","year":"2009","journal-title":"Eur Respir J"},{"issue":"5 Pt 1","key":"10.1016\/j.amjmed.2023.06.020_bib0007","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1164\/ajrccm.160.5.9901055","article-title":"A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy","volume":"160","author":"Dirksen","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.amjmed.2023.06.020_bib0008","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/15412550902905961","article-title":"Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis","volume":"6","author":"Chapman","year":"2009","journal-title":"COPD"},{"issue":"7","key":"10.1016\/j.amjmed.2023.06.020_bib0009","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/rccm.168.7.818","article-title":"American Thoracic Society\/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency","volume":"168","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.amjmed.2023.06.020_bib0010","first-page":"397","article-title":"Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting","volume":"75","year":"1997","journal-title":"Bull World Health Organ"},{"issue":"9","key":"10.1016\/j.amjmed.2023.06.020_bib0011","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.rmed.2013.04.023","article-title":"Alpha1-antitrypsin deficiency \u2013 diagnostic testing and disease awareness in Germany and Italy","volume":"107","author":"Greulich","year":"2013","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.amjmed.2023.06.020_bib0012","first-page":"322","article-title":"Knowledge of alpha-1 antitrypsin deficiency among internal medicine house officers and respiratory therapists: results of a survey","volume":"55","author":"Taliercio","year":"2010","journal-title":"Respir Care"},{"issue":"6","key":"10.1016\/j.amjmed.2023.06.020_bib0013","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0022-3476(78)80388-6","article-title":"Neonatal screening for alpha1-antitrypsin deficiency","volume":"92","author":"O'Brien","year":"1978","journal-title":"J Pediatr"},{"issue":"24","key":"10.1016\/j.amjmed.2023.06.020_bib0014","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM197606102942404","article-title":"Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants","volume":"294","author":"Sveger","year":"1976","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.amjmed.2023.06.020_bib0015","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1164\/ajrccm\/140.4.961","article-title":"Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening","volume":"140","author":"Silverman","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.amjmed.2023.06.020_bib0016","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2147\/COPD.S125389","article-title":"Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update","volume":"12","author":"Blanco","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"10.1016\/j.amjmed.2023.06.020_bib0017","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00360-2018","article-title":"Trends of testing for and diagnosis of \u03b1-1 antitrypsin deficiency in the UK: more testing is needed","volume":"52","author":"Soriano","year":"2018","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.amjmed.2023.06.020_bib0018","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02064-2018","article-title":"Challenges in interpreting trends in testing for \u03b1-1 antitrypsin deficiency in COPD patients from UK primary care","volume":"52","author":"Soriano","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.amjmed.2023.06.020_bib0019","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.arbres.2016.05.003","article-title":"Spanish registry of patients with alpha-1 antitrypsin deficiency: database evaluation and population analysis","volume":"53","author":"Lara","year":"2017","journal-title":"Arch Bronconeumol"},{"issue":"6","key":"10.1016\/j.amjmed.2023.06.020_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198777","article-title":"Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study","volume":"13","author":"Calle Rubio","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.amjmed.2023.06.020_bib0021","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1378\/chest.106.4.1223","article-title":"A registry of patients with severe deficiency of alpha-1 antitrypsin: design and methods","volume":"106","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2023.06.020_bib0022","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.rmed.2018.08.016","article-title":"Genotype is associated with smoking and other key health behaviors among individuals with alpha-1 antitrypsin deficiency-associated lung disease","volume":"143","author":"Holm","year":"2018","journal-title":"Respir Med"},{"issue":"11","key":"10.1016\/j.amjmed.2023.06.020_bib0023","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1164\/rccm.202005-1990OC","article-title":"Prevalence and population-attributable risk for chronic airflow obstruction in a large multinational study","volume":"203","author":"Burney","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.amjmed.2023.06.020_bib0024","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1197\/aemj.9.11.1184","article-title":"Achieving quality in clinical decision making: cognitive strategies and detection of bias","volume":"9","author":"Croskerry","year":"2002","journal-title":"Acad Emerg Med"},{"issue":"1","key":"10.1016\/j.amjmed.2023.06.020_bib0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1207\/s15324796abm3301_3","article-title":"Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency","volume":"33","author":"Carpenter","year":"2007","journal-title":"Ann Behav Med"},{"issue":"1","key":"10.1016\/j.amjmed.2023.06.020_bib0026","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/15412555.2020.1864725","article-title":"Alpha-1 antitrypsin deficiency and tobacco smoking: exploring risk factors and smoking cessation in a registry population","volume":"18","author":"Franciosi","year":"2021","journal-title":"COPD"},{"issue":"2","key":"10.1016\/j.amjmed.2023.06.020_bib0027","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/1753465810365158","article-title":"Ethnic differences in alpha-1 antitrypsin deficiency in the United States of America","volume":"4","author":"de Serres","year":"2010","journal-title":"Ther Adv Respir Dis"},{"issue":"2","key":"10.1016\/j.amjmed.2023.06.020_bib0028","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/bmmb.1993.1065","article-title":"Molecular confirmation of \u03b11-antitrypsin genotypes in newborn dried blood specimens","volume":"50","author":"Spence","year":"1993","journal-title":"Biochem Med Metab Biol"},{"issue":"2","key":"10.1016\/j.amjmed.2023.06.020_bib0029","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MPG.0000000000000196","article-title":"Appropriateness of newborn screening for \u03b11-antitrypsin deficiency","volume":"58","author":"Teckman","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.amjmed.2023.06.020_bib0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/15412550802587927","article-title":"Physician alert suggesting alpha-1 antitrypsin deficiency testing in pulmonary function test (PFT) results","volume":"6","author":"Rahaghi","year":"2009","journal-title":"COPD"},{"issue":"4","key":"10.1016\/j.amjmed.2023.06.020_bib0031","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/15412555.2012.669433","article-title":"The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction","volume":"9","author":"Rahaghi","year":"2012","journal-title":"COPD"},{"issue":"5","key":"10.1016\/j.amjmed.2023.06.020_bib0032","doi-asserted-by":"crossref","first-page":"667","DOI":"10.4187\/respcare.02817","article-title":"Detection of alpha-1 antitrypsin deficiency by respiratory therapists: experience with an educational program","volume":"59","author":"Stoller","year":"2014","journal-title":"Respir Care"},{"key":"10.1016\/j.amjmed.2023.06.020_bib0033","first-page":"A5353","article-title":"Alpha-1 antitrypsin genotype screening in COPD patient identified via EMR","volume":"183","author":"Choudry","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2023.06.020_bib0034","doi-asserted-by":"crossref","unstructured":"Campos M, Hagenlocker B, Lascano J, Riley L Impact of a computerized clinical decision support system to improve COPD diagnosis and testing for alpha-1 antitrypsin deficiency [online ahead of print]. Ann Am Thorac Soc. 2023. https:\/\/doi.org\/10.1513\/AnnalsATS.202211-954OC. Accessed March 29, 2023","DOI":"10.1513\/AnnalsATS.202211-954OC"},{"issue":"1","key":"10.1016\/j.amjmed.2023.06.020_bib0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1378\/chest.10-1658","article-title":"Impact of a clinical decision support system in an electronic health record to enhance detection of \u03b11-antitrypsin deficiency","volume":"140","author":"Jain","year":"2011","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.amjmed.2023.06.020_bib0036","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.chest.2021.09.041","article-title":"Prevalence of alpha-1 antitrypsin deficiency, self-reported behavior change, and health care engagement among direct-to-consumer recipients of a personalized genetic risk report","volume":"161","author":"Ashenhurst","year":"2022","journal-title":"Chest"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934323004321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934323004321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:30:52Z","timestamp":1757583052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934323004321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0002934323004321"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2023.06.020","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testing Patterns and Disparities for Alpha-1 Antitrypsin Deficiency","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2023.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}